454
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluations

Anacetrapib, a cholesteryl ester transfer protein inhibitor

&
Pages 103-109 | Published online: 22 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Michael M. Page, Amanda J. Hooper & John R. Burnett. (2016) Anacetrapib for the treatment of dyslipidaemia: the last bastion of the cholesteryl ester transfer protein inhibitors?. Expert Opinion on Pharmacotherapy 17:2, pages 275-281.
Read now
Damon A Bell, Amanda J Hooper, Gerald F Watts & John R Burnett. (2012) Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia. Vascular Health and Risk Management 8, pages 651-659.
Read now
Amanda J Hooper & John R Burnett. (2012) Dalcetrapib, a cholesteryl ester transfer protein modulator. Expert Opinion on Investigational Drugs 21:9, pages 1427-1432.
Read now

Articles from other publishers (6)

Xing Gao, Dongyu Zhu, Feng Jiang, Jianning Liao, Wei Wang, Yongjun Wu, Lufei Zheng & Hongchao Guo. (2021) Palladium-catalyzed stereoselective (3 + 2) cycloaddition of vinylethylene carbonates with cyclic N -sulfonyl ketimines . Organic & Biomolecular Chemistry 19:22, pages 4877-4881.
Crossref
Adam Meyer & John Ryan. (2016) 1,3-Dipolar Cycloaddition Reactions of Azomethine Ylides with Carbonyl Dipolarophiles Yielding Oxazolidine Derivatives. Molecules 21:8, pages 935.
Crossref
J Lu, Y Cleary, C Maugeais, CI Kiu Weber & NA Mazer. (2015) Analysis of “On/Off” Kinetics of a CETP Inhibitor Using a Mechanistic Model of Lipoprotein Metabolism and Kinetics. CPT: Pharmacometrics & Systems Pharmacology 4:8, pages 465-473.
Crossref
Wenquan NiuYue Qi. (2015) Circulating Cholesteryl Ester Transfer Protein and Coronary Heart Disease. Circulation: Cardiovascular Genetics 8:1, pages 114-121.
Crossref
M. Krempf. (2013) Pr?vention du risque cardiovasculaire : faut-il bloquer la CETP ?. M?decine des Maladies M?taboliques 7:6, pages 575-579.
Crossref
Tamio Teramoto, Masayoshi Shirakawa, Masashi Kikuchi, Mariko Nakagomi, Satoko Tamura, Howard K. Surks, Christine McCrary Sisk & Hirotaka Numaguchi. (2013) Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia. Atherosclerosis 230:1, pages 52-60.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.